CoChat

Are 5‐HT3antagonists effective in obsessive–compulsive disorder? A systematic review of literature

Serata, Daniele, Kotzalidis, Georgios D., Rapinesi, Chiara, Janiri, Delfina, Di Pietro, Simone, Callovini, Gemma, Piacentino, Daria, Gasperoni, Carlotta, Brugnoli, Roberto, Ferri, Vittoria Rachele, Girardi, Nicoletta, Tatarelli, Roberto, Ferracuti, Stefano, Angeletti, Gloria, Girardi, Paolo, Del Casale, Antonio · 2015 · Human Psychopharmacology: Clinical and Experimental
Cited by 30

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Objective: The purpose of this literature database search‐based review was to critically consider and evaluate the findings of literature focusing on efficacy and safety of 5‐HT 3 antagonists in the treatment of obsessive–compulsive disorder (OCD), so as to test whether preclinical data match clinical therapeutic trials. Design: The PubMed database has been searched for papers on 5‐HT 3 antagonists and OCD in humans and for animal models of OCD and 5‐HT 3 receptors. Results: Of the clinically tested 5‐HT 3 receptor antagonists, ondansetron has been used to treat OCD in five therapeutic studies, whereas granisetron only in one recent trial. Both showed some efficacy in open studies and superiority to placebo in double‐blind studies, along with fair safety. No animal OCD model directly implicated 5‐HT 3 receptors. Conclusions: Overall, results indicate some utility, but the available literature is too scanty to allow for valid conclusions to be drawn. The mismatch between animal models of obsessive–compulsive disorder and clinical data with 5‐HT 3 antagonists needs more clinical data to ensure that it is not an artefact. Copyright © 2015 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.2461

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 30

Metadata

Authors
Serata, D., Kotzalidis, G. D., Rapinesi, C., Janiri, D., Di Pietro, S., Callovini, G., Piacentino, D., Gasperoni, C., Brugnoli, R., Ferri, V. R., Girardi, N., Tatarelli, R., Ferracuti, S., Angeletti, G., Girardi, P., & Del Casale, A.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2015-02-10
Volume
30
Issue
2
Pages
70-84
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W1945842134
Cited by
30
References
17
FWCI
0.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are 5‐HT3antagonists effective in obsessive–compulsive disorder? A systematic review of literature. https://app.cochat.ai/papers/10.1002/hup.2461
The paper
Serata, D., Kotzalidis, G. D., Rapinesi, C., Janiri, D., Di Pietro, S., Callovini, G., Piacentino, D., Gasperoni, C., Brugnoli, R., Ferri, V. R., Girardi, N., Tatarelli, R., Ferracuti, S., Angeletti, G., Girardi, P., & Del Casale, A. (2015). Are 5‐HT3antagonists effective in obsessive–compulsive disorder? A systematic review of literature. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2461

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.